Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × tebentafusp × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Recruiting 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Melanoma 1

Interventions

pembrolizumab 169 Nivolumab 130 Specimen Handling 109 Carboplatin 106 Cyclophosphamide 99 Magnetic Resonance Spectroscopy 93 Paclitaxel 87 Biopsy 83 durvalumab 76 Cisplatin 76 Radiotherapy 75 Dexamethasone 75 atezolizumab 67 Ipilimumab 63 Lenalidomide 59 Gemcitabine 56 Rituximab 52 Docetaxel 52 Bevacizumab 50 olaparib 49 Doxorubicin 49 Fluorouracil 45 Oxaliplatin 43 Prednisone 41 Etoposide 40 Capecitabine 40 Radiosurgery 39 Radiation 38 Temozolomide 36 Leucovorin 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05315258 2025-07-17

TebeMRD

University of Oxford

Phase 2 Active not recruiting

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡